In 2026, the Company’s partner Chugai Pharmaceutical expects to submit a New Drug Application for sparsentan in Japan. Travere remains eligible to receive regulatory, development and sales-based ...
Preliminary unaudited Q4 and Full Year 2025 net Attruby®product revenue of $146.0 million and $362.4 million, respectively ...
Kristi Schaeffer Kleutsch of Kenosha has been selected to receive the 2026 Susan B. Anthony-Women of Influence Lifetime ...
Minnesota Timberwolves (26-14, fourth in the Western Conference) vs. Milwaukee Bucks (17-22, 11th in the Eastern Conference) ...